
Amylyx Pharmaceuticals, Inc.
USD18.70
+0.91 (+5.12%)
CEO
Joshua Cohen
IPO Date
2022-01-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.66
Prev. Close
$17.79
Day Low
$17.46
Day High
$18.75
52W Low
$5.97
52W High
$18.75
Market Cap
$1.55B
Volume
2.33M
| 19 Mar 2026 |
| Guggenheim |
| Buy |
| Buy |
| maintain |
| 4 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 20 Feb 2026 | B of A Securities | Buy | Buy | maintain |
| 10 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 7 Nov 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 17 Oct 2025 | Citigroup | Buy | Buy | maintain |
| 16 Oct 2025 | Baird | Outperform | Outperform | maintain |